Cameco Corp

Explore Cameco’s 2025 earnings surge: revenue up 9%, EPS +27%, and a disciplined supply strategy amid market‑price uncertainty and geopolitical risks.

How Came Co. balances rising Kazakhstan output, tech upgrades and regulatory pushes to stay ahead in a volatile uranium market.

Discover why Cameco’s stock hit a 52‑week high amid rising demand for uranium, SMR tech, and supportive green‑energy policies, and what this means for investors.

Comeco surges to a 52‑week high after TD Securities upgrades its rating and lifts the price target, driving higher trading and options activity amid growing investor interest in uranium’s role in the energy transition.

Explore why Cameco’s uranium stock is surging amid AI‑fuelled energy demand, yet valuation concerns and high option activity signal a cautious buying strategy.

Institutional investors add modest stakes in Came Co., a top‑tier Canadian uranium producer, signaling confidence in its robust cash flow, long‑term contracts and Westinghouse partnership while highlighting regulatory risks and market dynamics.

Explore Cameco’s 2023 performance, Westinghouse partnership, and regulatory outlook for uranium investors—gain insights into growth drivers and risks.

Explore how Cameco’s uranium supply and SMR readiness position it amid nuclear market tightening, rising demand, and evolving regulation.

Explore Cameco Corp’s dividend appeal, cost‑efficiency, and nuclear‑fuel risks—learn why investors are bullish yet cautious amid price swings, regulatory shifts, and future tech.

How Cameco’s modest stock rise mirrors the uranium market, decarbonisation trends, and Canada’s commodity rebound – insight into nuclear energy’s growing role.